A prospective, randomized, placebo‐controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Ng Ernest H.Y.   Lee Sharon W.H.   Ho Pak Chung  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2315-2318

Oxford University Press

Access to resources Recommend Favorite

Sublingual misoprostol for first trimester termination of pregnancy: safety concerns

By Chong Yap-Seng  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2777-2777

Oxford University Press

Access to resources Recommend Favorite

Sublingual misoprostol for first trimester termination of pregnancy: safety concerns

By Tang Oi-Shan  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2778-2778

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Kan Anita S.Y.   Ho Pak Chung  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3062-3066

Oxford University Press

Access to resources Recommend Favorite

Pregnancy and obstetrics. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability

By Ngai S.W.   Tang O.S.   Chan Y.M.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1159-1162

Oxford University Press

Access to resources Recommend Favorite